Exposure to androgen deprivation therapy and risk of anastomotic leakage after colorectal cancer surgery

Fuente: Wiley Open Access
Enregistré dans:
Détails bibliographiques
Auteurs principaux: Martin Rutegård, Isac Norrgård, John Moshtaghi‐Svensson, Jaana Hagström, Ida Hed Myrberg, Anna Lantz, Suvi Rasilainen, Caroline Nordenvall, Malin Sund
Format: Artículo Open Access
Publié: Wiley 2025
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1867012671804538880
author Martin Rutegård
Isac Norrgård
John Moshtaghi‐Svensson
Jaana Hagström
Ida Hed Myrberg
Anna Lantz
Suvi Rasilainen
Caroline Nordenvall
Malin Sund
author_facet Martin Rutegård
Isac Norrgård
John Moshtaghi‐Svensson
Jaana Hagström
Ida Hed Myrberg
Anna Lantz
Suvi Rasilainen
Caroline Nordenvall
Malin Sund
Martin Rutegård
Isac Norrgård
John Moshtaghi‐Svensson
Jaana Hagström
Ida Hed Myrberg
Anna Lantz
Suvi Rasilainen
Caroline Nordenvall
Malin Sund
collection Wiley Open Access
contents Exposure to androgen deprivation therapy and risk of anastomotic leakage after colorectal cancer surgery Martin Rutegård Isac Norrgård John Moshtaghi‐Svensson Jaana Hagström Ida Hed Myrberg Anna Lantz Suvi Rasilainen Caroline Nordenvall Malin Sund Colorectal Disease AbstractAimThe risk of anastomotic leakage after colorectal cancer surgery is higher in men, regardless of the anatomical location. Previous studies suggest that this might be due to hormonal differences. The aim of this work was to investigate whether androgen deprivation therapy influenced the incidence of anastomotic leakage.MethodThis is a nationwide registry‐based study of men operated on between 2007 and 2021 for colorectal cancer with an anastomosis. Exposure to androgen deprivation therapy (prescribed drugs or surgical castration) was related to anastomotic leakage using mixed‐effects logistic regression models. Two control groups were formed: one without and one with prostate cancer but without androgen deprivation. To study the potential target for androgen effect in intestinal tissue, androgen receptor expression was evaluated using immunohistochemistry in a smaller independent cohort to compare receptor expression in relation to leakage.ResultsSome 24 611 men were included in the registry study, of whom 2.4% were exposed to androgen deprivation therapy. In this exposed group, compared with unexposed men with and without prostate cancer, respectively, leak rates were 3.7%, 5.6% and 5.8%, respectively. After adjustment, a nonsignificant reduction of anastomotic leakage in the exposed group was detected (OR 0.70, 95% CI 0.45–1.09) compared with men without prostate cancer. Tissue expression of androgen receptor was very low among patients with and without leakage, albeit with a trend of higher expression among the latter.ConclusionAnastomotic leakage rates might be lower in men exposed to androgen deprivation therapy before surgery for colorectal cancer, although this finding must be interpreted cautiously. Effects on anastomotic healing do not seem to be mediated through classical androgen receptor signalling in the intestine. 10.1111/codi.70126 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1111/codi.70126
format Artículo Open Access
id wiley_oa_10_1111_codi_70126
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Exposure to androgen deprivation therapy and risk of anastomotic leakage after colorectal cancer surgery
Martin Rutegård
Isac Norrgård
John Moshtaghi‐Svensson
Jaana Hagström
Ida Hed Myrberg
Anna Lantz
Suvi Rasilainen
Caroline Nordenvall
Malin Sund
Colorectal Disease
Exposure to androgen deprivation therapy and risk of anastomotic leakage after colorectal cancer surgery Martin Rutegård Isac Norrgård John Moshtaghi‐Svensson Jaana Hagström Ida Hed Myrberg Anna Lantz Suvi Rasilainen Caroline Nordenvall Malin Sund Colorectal Disease AbstractAimThe risk of anastomotic leakage after colorectal cancer surgery is higher in men, regardless of the anatomical location. Previous studies suggest that this might be due to hormonal differences. The aim of this work was to investigate whether androgen deprivation therapy influenced the incidence of anastomotic leakage.MethodThis is a nationwide registry‐based study of men operated on between 2007 and 2021 for colorectal cancer with an anastomosis. Exposure to androgen deprivation therapy (prescribed drugs or surgical castration) was related to anastomotic leakage using mixed‐effects logistic regression models. Two control groups were formed: one without and one with prostate cancer but without androgen deprivation. To study the potential target for androgen effect in intestinal tissue, androgen receptor expression was evaluated using immunohistochemistry in a smaller independent cohort to compare receptor expression in relation to leakage.ResultsSome 24 611 men were included in the registry study, of whom 2.4% were exposed to androgen deprivation therapy. In this exposed group, compared with unexposed men with and without prostate cancer, respectively, leak rates were 3.7%, 5.6% and 5.8%, respectively. After adjustment, a nonsignificant reduction of anastomotic leakage in the exposed group was detected (OR 0.70, 95% CI 0.45–1.09) compared with men without prostate cancer. Tissue expression of androgen receptor was very low among patients with and without leakage, albeit with a trend of higher expression among the latter.ConclusionAnastomotic leakage rates might be lower in men exposed to androgen deprivation therapy before surgery for colorectal cancer, although this finding must be interpreted cautiously. Effects on anastomotic healing do not seem to be mediated through classical androgen receptor signalling in the intestine. 10.1111/codi.70126 http://creativecommons.org/licenses/by/4.0/
title Exposure to androgen deprivation therapy and risk of anastomotic leakage after colorectal cancer surgery
topic Colorectal Disease
url https://onlinelibrary.wiley.com/doi/10.1111/codi.70126